Our products – closer to health

More and more users worldwide are discovering the product advantages of EmboCept® S in DSM-TACE with degradable starch microspheres. EmboCept® S has also been approved for the treatment of lung tumors.

PlatiCept®, a lyophilized cisplatin, is ideal for use in interventional oncology. PlatiCept®  is approved in Spain and Germany.